Who Brands - Brand Ownership DirectoryWho Brands
HomeBrowse BrandsCategoriesCompaniesCompareBlogQuizAbout
HomeBrowse BrandsCategoriesCompaniesCompareBlogQuizAbout
Who Brands

Your trusted reference for brand ownership information. We provide factual, comprehensive data about who owns the brands you know.

Stay in the know

Get the latest ownership updates delivered to your inbox.

Browse

  • All Brands
  • Categories
  • Companies
  • Countries
  • Compare Brands
  • Blog
  • Brand Quiz
  • RSS Feed

Company

  • About Us
  • Methodology
  • Contact
  • FAQ
  • Submit a Brand
  • List Your Brand
  • Write for Us

Legal

  • Terms of Service
  • Privacy Policy
  • Cookie Policy
  • Affiliate Disclosure
  • Disclaimer

Support Us

☕Buy me a coffee

2026 Who Brands. All information is provided for educational purposes. Brand names and logos are trademarks of their respective owners.

  1. Home
  2. Brands
  3. Healthcare & Pharmaceuticals
  4. Cardinal Health At-Home
Cardinal Health At-Home logo
Healthcare & Pharmaceuticals

Who Owns Cardinal Health At-Home?

Cardinal Health At-Home is owned by Cardinal Health, Inc. (NYSE: CAH), a publicly traded American healthcare company headquartered in Dublin, Ohio. The division operates as a wholly-owned brand within Cardinal Health's Other segment, delivering medical supplies, equipment, and pharmacy services directly to patients in the United States. Cardinal Health reported $222.6 billion in fiscal year 2025 revenue and continues expanding its at-home capabilities through acquisitions.

Parent Company

Cardinal Health

Founded

2014

Status

Publicly Traded

Headquarters

Dublin, Ohio, USA

Cardinal Health At-Home Timeline

1971
Cardinal Health

Parent company established in Dublin, Ohio, USA

Company Founded
2014

Cardinal Health At-Home

Founded by Cardinal Health

Founded
United StatesOfficial Website

Who Owns Cardinal Health At-Home?

  • Parent Company: Cardinal Health
  • Ownership Type: Brand division
  • Company Type: Publicly Traded
  • Stock Ticker: NYSE: CAH
BrandParent CompanyOwnership Type
Cardinal Health At-HomeCardinal HealthBrand division

Where to Buy

Disclosure: We may earn commission from purchases
AmazonCardinal Health At-Home on Amazon

History of Cardinal Health At-Home

  • Founded: 2014
  • Founders: Cardinal Health

Cardinal Health launched its at-Home Solutions business in 2014 as part of a broader strategy to diversify beyond its core pharmaceutical distribution operations. The initial focus was providing durable medical equipment and disposable medical supplies to patients managing chronic conditions at home.

The division grew slowly in its early years. Cardinal Health was primarily known as a pharmaceutical wholesaler, and the at-home market was a small fraction of its total business. The company supplied products for diabetes management, wound care, urology, ostomy, and incontinence through partnerships with health plans and providers.

A turning point came in 2024 when Cardinal Health acquired Advanced Diabetes Supply (ADS), a direct-to-patient diabetes supply company. The ADS acquisition gave Cardinal Health a national platform for shipping continuous glucose monitors, insulin pump supplies, and testing strips directly to patients' homes. It also brought an established customer base and relationships with major insurance plans.

Following the ADS acquisition, Cardinal Health integrated the business into its at-Home Solutions distribution network. The company migrated all ADS volume onto its technology-enabled distribution platform. According to Cardinal Health, the integration was completed ahead of plan. The division onboarded nearly 500,000 new customers in the first year after closing the ADS deal.

In 2025, Cardinal Health launched the ContinuCare Pathway program. This is a digital referral system that connects partner pharmacies with at-Home Solutions for diabetes supply fulfillment. The program allows pharmacies to refer patients who need diabetes supplies directly to Cardinal Health's distribution network. Cardinal Health announced a key partnership with Publix Super Markets Inc. as part of this initiative.

The company also expanded through its Specialty Alliance platform. In November 2025, The Specialty Alliance completed the acquisition of Solaris Health, the country's largest urology management services organization (MSO) with over 750 providers. While Solaris Health operates under the Specialty Solutions segment rather than at-Home Solutions, it creates referral pathways for urology patients who may need home-based medical supplies.

In July 2026, Cardinal Health announced two more acquisitions to accelerate its at-Home Solutions growth. The company agreed to acquire the Diabetes Health business of AdaptHealth Corp. (NASDAQ: AHCO) and Strive Medical, a multi-specialty supply provider focused on urology. The combined transaction value is approximately $360 million in cash. Both deals are expected to close subject to regulatory approvals and customary closing conditions.

CEO Jason Hollar described these acquisitions as a natural extension of the at-Home Solutions growth strategy. They expand Cardinal Health's depth in diabetes management and urology, two therapeutic categories with significant home-care demand. The transactions are expected to be accretive to non-GAAP earnings per share within the first 12 months following close.

Rob Schlissberg, President of at-Home Solutions, stated that the operational achievements in fiscal year 2026 position Cardinal Health to continue building what he called the country's leading platform for home-based care. The company is pursuing both organic growth and acquisitions to expand its capabilities.

Cardinal Health's at-Home Solutions business is still small relative to the company's Pharmaceutical and Specialty Solutions segment, which generated $687 million in segment profit alone in the second quarter of fiscal year 2026. But the Other segment's 31% revenue growth rate significantly outpaces the core pharmaceutical distribution business, making at-Home Solutions a strategic priority for future expansion.

About Cardinal Health

Is Cardinal Health a subsidiary of another company?
No. Cardinal Health is an independent, publicly traded corporation with no parent company. The company operates independently with its own management structure and board of directors, though it has grown through numerous acquisitions throughout its history.

Is Cardinal Health publicly traded?
Yes. Cardinal Health is publicly traded on the New York Stock Exchange under the ticker symbol CAH. The company has been publicly traded since its IPO in 1983.

When was Cardinal Health founded?
Cardinal Health was founded in 1971 by Robert Walter as a food distributor in Columbus, Ohio. The company entered the pharmaceutical distribution business in 1979, marking the beginning of its transformation into a healthcare services company.

Who founded Cardinal Health?
Cardinal Health was founded by Robert Walter, who started the company as a small food distributor in Columbus, Ohio. Walter's vision and leadership guided the company's transformation into one of the largest healthcare distribution companies in the world.

What is Cardinal Health's annual revenue?
Cardinal Health reported FY2025 revenue of $222.6 billion (fiscal year ended June 30, 2025), a 2 percent decrease from FY2024 due to the OptumRx contract expiration. Excluding this impact, revenue increased 18 percent. Through the first three quarters of FY2026, revenue was $190.6 billion, up 17 percent year-over-year.

Who is Cardinal Health's CEO?
Jason Hollar serves as CEO of Cardinal Health. Hollar described FY2025 as a "transformative year" and has led the company's strategic shift toward specialty healthcare services through The Specialty Alliance MSO platform.

What is The Specialty Alliance?
The Specialty Alliance is Cardinal Health's multi-specialty management services organization (MSO) platform, providing administrative and management services to physician practices. It includes GI Alliance (gastroenterology with 900+ physicians), Urology Alliance (urology with 750+ providers through Solaris Health and other acquisitions), and Navista (oncology with 50+ practice sites). Cardinal Health owns approximately 75 percent of The Specialty Alliance following the Solaris Health acquisition.

What is Cardinal Health's opioid settlement obligation?
Cardinal Health has $4.9 billion accrued as of June 30, 2025 for opioid litigation settlements, including the National Opioid Settlement Agreement (NOSA). The company made payments of $798 million in FY2025 and a fifth annual NOSA payment of $366 million in July 2025. The majority of remaining payments are expected through 2038.

  • Founded: 1971
  • Headquarters: Dublin, Ohio, USA
  • Company Type: Publicly Traded
  • Stock: NYSE: CAH
  • Revenue: $222.6 billion (FY2025)
  • Employees: Approximately 49,000

Visit Cardinal Health website

View full company profile for Cardinal Health

Where Is Cardinal Health At-Home Made / Based?

  • Headquarters: Dublin, Ohio, USA
  • Manufacturing / Operations: United States

Cardinal Health At-Home Categories & Tags

At Home HealthcareMedical SuppliesHome DeliveryPatient CareCardinal Health

Cardinal Health At-Home Sustainability & Ethics

Cardinal Health publishes an annual ESG report covering environmental impact, social responsibility, and governance practices. The company has set targets for reducing greenhouse gas emissions and has invested in sustainable packaging for its medical product lines.

However, the at-Home Solutions division does not have independently verified sustainability certifications from recognized third-party organizations. The standard certifications tracked in consumer goods, such as cruelty-free, vegan, B Corp, or organic certifications, do not apply to a B2B medical supply distribution business.

Cardinal Health's ethics practices include a code of conduct for employees and suppliers, compliance training programs, and a whistleblower hotline. The company is subject to FDA regulations governing medical device distribution and must maintain compliance with the Drug Supply Chain Security Act for pharmaceutical distribution.

In terms of social impact, Cardinal Health's at-Home Solutions improves healthcare access for patients with limited mobility or those living in rural areas. The direct-to-patient model reduces barriers to obtaining essential medical supplies for chronic condition management.

Awards & Recognition

Cardinal Health as a parent company has received recognition for its workplace culture and business performance. The company has been named to the Forbes list of America's Best Employers and has received recognition from the Human Rights Campaign for LGBTQ+ workplace equality.

The at-Home Solutions division specifically has not been the subject of major industry awards as of August 2026. The division's growth strategy and acquisitions have been noted in healthcare industry publications, but formal awards at the division level are limited.

Cardinal Health At-Home Recalls & Controversies

Cardinal Health has faced regulatory scrutiny at the corporate level that indirectly affects its at-Home Solutions business. In April 2024, the FDA issued a warning letter to Cardinal Health's facility in Waukegan, Illinois, related to quality system violations for medical device distribution. The letter cited failures in complaint handling and corrective action procedures. Cardinal Health responded with a remediation plan and has stated that it is working to address all FDA observations.

The company has also faced litigation related to its role in the opioid epidemic. Cardinal Health was one of several pharmaceutical distributors that settled with states, local governments, and tribal nations for a combined total exceeding $20 billion across the industry. Cardinal Health's specific settlement obligations extend over 18 years and have been incorporated into the company's financial reporting.

The at-Home Solutions division itself has not been the subject of specific recalls or controversies. However, the July 2026 acquisition of AdaptHealth's diabetes business brings potential exposure to AdaptHealth's historical regulatory issues, including a 2023 data breach that affected over 12,000 patients. Cardinal Health will need to integrate AdaptHealth's diabetes operations while ensuring compliance with HIPAA and data security standards.

Brands Owned by Cardinal Health

Cardinal Health Nuclear & Precision Health SolutionsHealthcare Pharmaceuticals

Cardinal Health Nuclear & Precision Health Solutions

Owned by Cardinal Health

Nuclear and precision health solutions division of Cardinal Health, supplying radiopharmaceuticals, diagnostic imaging agents, and theranostics to hospitals and clinical research networks.

nuclear-medicineradiopharmaceuticalstheranostics
Cardinal Health Specialty PharmacyHealthcare Pharmaceuticals

Cardinal Health Specialty Pharmacy

Owned by Cardinal Health

Specialty pharmacy division of Cardinal Health, providing distribution and management services for high-cost, complex medications used in oncology, rheumatology, and other specialty therapeutic areas.

specialty-pharmacypharmaceutical-distributiononcology
Edgepark Medical SuppliesHealthcare Pharmaceuticals

Edgepark Medical Supplies

Owned by Cardinal Health

Direct-to-consumer medical supply company owned by Cardinal Health, serving patients with diabetes, ostomy, and urology products.

medical-supplieshome-medical-equipmentdirect-to-consumer
View all brands owned by Cardinal Health

Sources & Further Reading

  • [Cardinal Health Investor Relations](
  • [Cardinal Health Q2 FY2026 Results](
  • [Cardinal Health Q3 FY2026 Results](
  • [Cardinal Health at-Home Solutions Acquisitions Announcement, July 2026](
  • [Cardinal Health FY2025 Annual Results](
  • [Cardinal Health SEC Filings](
  • [Simply Wall St: Cardinal Health Analysis](

Competitors to Cardinal Health At-Home

No direct competitors found in the same category. This could be because Cardinal Health At-Homeoperates in a unique market segment or we're still building our competitor database.

Independent Alternatives to Cardinal Health At-Home

Looking for brands with different ownership structures? These similar brands are not owned by Cardinal Health, giving you alternative choices that support different corporate structures.

BootsHealthcare Pharmaceuticals

Boots

Owned by Walgreens Boots Alliance

Boots is the UK's leading pharmacy-led health and beauty retailer, founded in 1849, now operating as The Boots Group under Sycamore Partners since August 2025.

pharmacyhealth-beautyuk-retail
Privately Owned

Boots is privately owned, unlike Cardinal Health At-Home which is under a publicly traded parent company.

Duane ReadeHealthcare Pharmaceuticals

Duane Reade

Owned by Walgreens Boots Alliance

Duane Reade is a New York City drugstore chain owned by Walgreen Co. under Sycamore Partners, operating approximately 90 stores across the five boroughs.

pharmacydrugstorenew-york
Privately Owned

Duane Reade is privately owned, unlike Cardinal Health At-Home which is under a publicly traded parent company.

Pharmacy DirectHealthcare Pharmaceuticals

Pharmacy Direct

Owned by Chempro Chemists

Australian online pharmacy operated by Chempro Chemists from Molendinar, Queensland. Offers prescription medications, health products, and wellness items through digital platforms and mail-order delivery.

online-pharmacymail-orderdigital-health
Privately Owned

Pharmacy Direct is privately owned, unlike Cardinal Health At-Home which is under a publicly traded parent company.

RetavaseHealthcare Pharmaceuticals

Retavase

Owned by EKR Therapeutics, Inc.

Retavase (reteplase) is a prescription thrombolytic medication indicated for acute ST-elevation myocardial infarction. Administered as two 10-unit intravenous bolus injections 30 minutes apart. Currently marketed by Chiesi USA.

pharmaceuticalthrombolyticreteplase
Privately Owned

Retavase is privately owned, unlike Cardinal Health At-Home which is under a publicly traded parent company.

TirosintHealthcare Pharmaceuticals

Tirosint

Owned by IBSA Institut Biochimique S.A.

IBSA Institut Biochimique SA's branded levothyroxine softgel capsule (Tirosint) and liquid solution (Tirosint-SOL), FDA approved for hypothyroidism, formulated without dyes, gluten, lactose, alcohol, or sugar, providing an excipient-free alternative to conventional levothyroxine tablets for patients with sensitivities or absorption issues.

levothyroxinehypothyroidismthyroid
Privately Owned

Tirosint is privately owned, unlike Cardinal Health At-Home which is under a publicly traded parent company.

WalgreensHealthcare Pharmaceuticals

Walgreens

Owned by Walgreens Boots Alliance

Walgreens is the largest U.S. pharmacy retail brand, operating roughly 8,000 stores. It went private in August 2025 under Sycamore Partners as a standalone company.

pharmacydrugstoreretail-pharmacy
Privately Owned

Walgreens is privately owned, unlike Cardinal Health At-Home which is under a publicly traded parent company.

Cardinal Health Stock Information

Jobs at Cardinal Health

Latest News About Cardinal Health At-Home

Related Articles About Cardinal Health At-Home

View more articles
Netflix vs Disney Plus: Corporate Parents Compared
Rivalry

Netflix vs Disney Plus: Corporate Parents Compared

Netflix has 325M+ subscribers as an independent public company ($51B 2026 revenue target). Disney fully owns Disney+ and Hulu after buying Comcast's stake for ~$9B. Theme parks are Disney's profit engine. Explore our database.

Who Brands StaffOct 19, 2026
NetflixDisney PlusRivalry
Spotify vs Apple Music: The Ownership Battle
Rivalry

Spotify vs Apple Music: The Ownership Battle

Spotify has 300M subscribers (31.4% share) as an independent public company. Apple Music has ~100M inside Apple's $31B Services segment. Spotify pays $0.003/stream; Apple pays $0.007. Discover the ownership battle.

Who Brands StaffOct 18, 2026
SpotifyApple MusicRivalry
Uber vs Lyft: Corporate Ownership and Investors
Rivalry

Uber vs Lyft: Corporate Ownership and Investors

Uber's largest investors are Vanguard, BlackRock, and Saudi PIF (3.57%). SoftBank exited entirely. Lyft's founders converted super-voting shares in Aug 2025. Discover Uber vs Lyft ownership. Explore our database.

Who Brands StaffOct 17, 2026
UberLyftRivalry
View more articles

People Also Searched

Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.

Abbokinase
Brandpharmaceutical

Abbokinase

Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.

Brand in Healthcare & Pharmaceuticals
thrombolyticurokinase
Abrysvo
Brandrsv-vaccine

Abrysvo

Pfizer's respiratory syncytial virus (RSV) vaccine approved for older adults, maternal immunization to protect infants, and younger at-risk adults. Launched 2023.

Brand in Healthcare & Pharmaceuticals
vaccinesmaternal-immunization
Accutane
Branddermatology

Accutane

Prescription isotretinoin brand developed by Roche and approved by the FDA in 1982 for severe nodular acne. Roche discontinued the brand name in the United States in 2009; the drug continues as Roaccutane in international markets.

Brand in Healthcare & Pharmaceuticals
acne-treatmentprescription
Browse All Healthcare & Pharmaceuticals

Last reviewed: August 1, 2026 · Reviewed by Who Brands Editorial Team